Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Temporal and Global Trends of the Incidence of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Omar Abdelfattah, Matthew W. Martinez, Ahmed Sayed, et al.
JACC. Clinical electrophysiology (2022) Vol. 8, Iss. 11, pp. 1417-1427
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Zaid Almarzooq, et al.
Circulation (2024) Vol. 149, Iss. 8
Open Access | Times Cited: 934
T1 Mapping and Interstitial Fibrosis as a Marker for Heart Failure in Hypertrophic Cardiomyopathy
Saad Ur Rahman, Ethan J. Rowin
Circulation Cardiovascular Imaging (2025)
Closed Access | Times Cited: 1
The Paradigm of Sudden Death Prevention in Hypertrophic Cardiomyopathy
Martin S. Maron, Ethan J. Rowin, Barry J. Maron
The American Journal of Cardiology (2024) Vol. 212, pp. S64-S76
Open Access | Times Cited: 6
A systematic review of present and future pharmaco‐structural therapies for hypertrophic cardiomyopathy
Mariem A. Sawan, Sindhu Prabakaran, Melroy D'Souza, et al.
Clinical Cardiology (2024) Vol. 47, Iss. 1
Open Access | Times Cited: 5
Development of the Implantable Cardioverter-Defibrillator
Barry J. Maron, N.A. Mark Estes, Ethan J. Rowin, et al.
Journal of the American College of Cardiology (2023) Vol. 82, Iss. 4, pp. 353-373
Open Access | Times Cited: 13
Global and Temporal Trends in Utilization and Outcomes of Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy
Omar Abdelfattah, Ahmed Sayed, Ahmed Al-Jwaid, et al.
Circulation Arrhythmia and Electrophysiology (2025)
Closed Access
Echocardiography in the cardiac assessment of young athletes: a 2025 guideline from the British Society of Echocardiography (endorsed by Cardiac Risk in the Young)
David Oxborough, Keith George, Robert Cooper, et al.
Echo Research and Practice (2025) Vol. 12, Iss. 1
Open Access
Exploring the Current Status of Risk Stratification in Hypertrophic Cardiomyopathy: From Risk Models to Promising Techniques
Alexandros Kasiakogias, Christos Kaskoutis, C. Antoniou, et al.
Journal of Cardiovascular Development and Disease (2025) Vol. 12, Iss. 3, pp. 101-101
Open Access
Evidence of Declining Mortality Trends for Hypertrophic Cardiomyopathy in the United States and the Impact of the COVID‐19 Pandemic
Ahmed Sayed, Barry J. Maron, Ethan J. Rowin, et al.
Journal of the American Heart Association (2025)
Open Access
Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023
Barry J. Maron, Ethan J. Rowin, Martin S. Maron
The American Journal of Cardiology (2024) Vol. 212, pp. S77-S82
Open Access | Times Cited: 3
Use of Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death in Asia
Nobuhiko Ueda, Takashi Noda, Kengo Kusano, et al.
JACC Asia (2023) Vol. 3, Iss. 3, pp. 335-345
Open Access | Times Cited: 8
Re-examining family history of sudden death as a risk marker in hypertrophic cardiomyopathy
Konstantinos C. Siontis, Steven R Ommen, Martin S. Maron, et al.
Heart Rhythm (2024) Vol. 21, Iss. 10, pp. 1838-1842
Closed Access | Times Cited: 2
Risk Stratification in Hypertrophic Cardiomyopathy
Monica Ahluwalia, Jacques Kpodonu, Emmanuel Agu
JACC Advances (2023) Vol. 2, Iss. 7, pp. 100562-100562
Open Access | Times Cited: 5
Tricuspid valve surgery following septal myectomy in patients with a cardiac implantable electronic device
Tedy Sawma, Hartzell V. Schaff, Jeffrey B. Geske, et al.
JTCVS Open (2024)
Open Access | Times Cited: 1
Clinical Outcomes in Hypertrophic Cardiomyopathy and No Late Gadolinium Enhancement
Omar Abdelfattah, Xander Jacquemyn, Amro Aglan, et al.
JACC. Cardiovascular imaging (2024) Vol. 17, Iss. 11, pp. 1387-1388
Closed Access | Times Cited: 1
Unmet needs and future directions in hypertrophic cardiomyopathy
Simrat Kaur, Milind Y. Desai
Progress in Cardiovascular Diseases (2023) Vol. 80, pp. 1-7
Closed Access | Times Cited: 3
Art and science of risk stratification of sudden cardiac death in hypertrophic cardiomyopathy: Current state, unknowns, and future directions
Konstantinos C. Siontis, Steve R. Ommen, Jeffrey B. Geske
Progress in Cardiovascular Diseases (2023) Vol. 80, pp. 25-31
Closed Access | Times Cited: 3
Primary Prevention of Sudden Cardiac Death in Asia
Chu‐Pak Lau, Hung‐Fat Tse
JACC Asia (2023) Vol. 3, Iss. 3, pp. 346-348
Open Access | Times Cited: 2
Exercise in Hypertrophic Cardiomyopathy: Recent Conceptual Changes and Recommendations for Pre-Exercise Tests
Jiwon Seo, Eui‐Young Choi, Se‐Joong Rim
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 6
Open Access | Times Cited: 1
Myocardial Strain for Predicting Risk of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Wen‐Chung Yu
JACC Asia (2024) Vol. 4, Iss. 1, pp. 23-24
Open Access
Revolutionizing Cardiac Care: A Comprehensive Review of ECG-Based Arrhythmia Prediction Techniques
Akhil Dhiman, Raj Kumar, Harsh Karki, et al.
Lecture notes in networks and systems (2024), pp. 503-515
Closed Access
How Investigative Reporting and the ‘Fourth Estate’ Saved Hypertrophic Cardiomyopathy…Twice
Barry J. Maron
The American Journal of Medicine (2024) Vol. 137, Iss. 7, pp. 561-563
Open Access
The Current Landscape of Ventricular Tachycardia Trials: A Systematic Review of Registered Studies
Anunay Gupta, Vlad Danaila, Kasun De Silva, et al.
Heart Lung and Circulation (2024) Vol. 33, Iss. 8, pp. 1082-1096
Closed Access
A Cautionary Tale of Hypertrophic Cardiomyopathy—From “Benign” Left Ventricular Hypertrophy to Stroke, Atrial Fibrillation, and Molecular Genetic Diagnostics: A Case Report and Review of Literature
Dolina Gencheva, Petya Angelova, K. Genova, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9385-9385
Open Access
Long-Term Impact of Pregnancy on Clinical Outcomes in Individuals with Hypertrophic Cardiomyopathy
Jasmin Abdeldayem, Omar Abdelfattah, Omar Chaabo, et al.
JACC Advances (2024) Vol. 4, Iss. 1, pp. 101426-101426
Open Access
Page 1 - Next Page

Scroll to top